As Earth Day approaches, CSL is reflecting on recent accomplishments while also looking ahead to what’s next: seeking the validation of its emissions targets by the Science Based Targets Initiative (SBTi), Chief Sustainability Officer Jeffrey Ball said.
SBTi is a nonprofit collaboration that has helped guide thousands of businesses to choose emissions targets. CSL seeks to submit its targets in July, Ball said in a video message.
Ball also shared strides CSL has made so far, including an agreement finalized in October with Australian energy supplier AGL. In the seven-year agreement, CSL will match 100% of the electricity used by its Australian manufacturing sites with renewable energy certificates. The company has also achieved 100% renewable electricity purchased from certified sources across its European manufacturing facilities.
CSL is a global biotech that includes business units CSL Behring, which makes medicines for people who have rare and serious diseases; CSL Seqirus, which develops and manufactures vaccines; and CSL Vifor, a leader in iron deficiency and nephrology (kidney care).
